Report: Valieva tests positive for banned heart medication

The Associated Press
Kamila Valieva, of the Russian Olympic Committee, competes in the women’s team free skate program during the figure skating competition at the 2022 Winter Olympics, on Monday n Beijing.

BEIJING (AP) — Olympic favorite Kamila Valieva tested positive for a banned heart medication before her arrival at the Beijing Olympics, the Russian newspaper RBC reported, putting in jeopardy the team gold medal that she helped win earlier this week.

The sample was reportedly obtained in December, when the 15-year-old Valieva was still in Russia but did not come to light until after she had helped her team win the gold medal with dynamic performances in her short program and free skate.

The drug, Trimetazidine, is used to to treat angina — a type of chest pain marked by reduced blood flow to the heart — and is banned by the World Anti-Doping Agency as a stimulant. It is the same drug that was involved in a Russian bobsled case at the 2018 Olympics that ended in a settlement and the athletes accepting an eight-month ban.

It is unclear whether Valieva has any heart problems.